According to our new research study on "Poultry Vaccines Market Size and Forecast to 2031 -Impact and Country Analysis - by Type, Technology, Dosage Form, Disease, Route of Administration, and End User," the poultry vaccines market size is projected to grow from US$ 2.1 billion in 2023 to US$ 4.1 billion by 2031; the market is estimated to record a CAGR of 8.6% during 2023-2031. The poultry vaccines market report emphasizes key driving factors such as the rising prevalence of poultry diseases. However, vaccination failure and improper handling of vaccines impede the market growth. The advancements in vectored and combination vaccines are likely to remain key poultry vaccines market trends.

Market Opportunity

Advancements in Vectored and Combination Vaccines

Vectored vaccines work differently from conventional vaccines and offer several advantages. These advantages include no adverse effects/reactions, overcoming maternal antibody interference, and meeting evolving disease challenges, among others. The "Vaxxitek HVT+IBD+ND" is an example of a vector vaccine manufactured by Boehringer Ingelheim and was launched in the US market in 2019. It is a trivalent vaccine and is effective against three diseases: Marek's Disease (MD), Infectious Bursal Disease (IBD), and Newcastle disease (ND). Additionally, in 2020, a second trivalent form, "Vaxxitek HVT+IBD+ILT," received marketing authorization in the US to protect against MD, IBD, and Infectious Laryngotracheitis (ILT). These are all highly infectious and commercially disruptive diseases that affect the poultry industry worldwide, and Vaxxitek proves beneficial in overcoming such diseases in one shot. Other manufacturers except Boehringer Ingelheim producing such bivalent and trivalent vaccines will enhance global demand. Also, major manufacturers plan to procure pentavalent vaccines that will prove beneficial to overcome poultry diseases and help them stand out in the global market. Thus, the advancements in vectored and combination vaccines production acts as a new trend that is likely to boost the poultry vaccines market growth in the coming years.

Report Segmentation and Scope:

Key segments that contributed to the derivation of the poultry vaccines market analysis are type, technology, dosage form, disease, route of administration, and end user.

- Based on type, the poultry vaccines market is divided into broiler and layer. The broiler segment held a larger market share in 2023.

- By technology, the market is segmented into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest share of the market in 2023.

- In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023.

- In terms of disease, the market is segmented into avian influenza, avian salmonellosis, Marek's disease, infectious bronchitis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment dominated the market in 2023.

- In terms of route of administration, the market is categorized into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment dominated the market in 2023.

In terms of end user, the market is segmented into poultry farms, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms segment dominated the market in 2023.



Technology-Based Insights

By technology, the poultry vaccines market is segmented as live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest share of the market in 2023. The live attenuated vaccines segment held the largest share of the poultry vaccines market by technology segment in 2023. Attenuated or modified live vaccines are made by weakening the disease microbe, by culturing the pathogen in the laboratory until it loses or reduces its ability to cause disease and then providing a small dose of the organism during vaccination. However, an attenuated vaccine is effective if it shows a mild immune response by growing within the bird. Live attenuated vaccines are a part of the most effective vaccine category as they offer rapid and long-lasting responses, are less expensive, and cause fewer allergic reactions than other vaccines. The vaccination of poultry using genetically modified, live attenuated vaccines is increasingly becoming popular worldwide. A vaccine based on the O78:K80 E. coli strain with aroA gene deletion is commercially available. Gallimune is a polyvalent attenuated live and inactivated vaccine produced by Boehringer Ingelheim, which contains antigens for vaccination against Avian Influenza, Newcastle Disease, Avian Coryza, Egg Drop Syndrome, Infectious Bronchitis, and Infectious Bursal Disease. Therefore, live attenuated vaccine will bolsterthe poultry vaccines market growth during the forecast period.

Dosage Form-Based Insights

In terms of dosage form, the market is categorized into liquid vaccines, freeze-dried vaccines, and dust/powder form vaccines. The liquid vaccines segment dominated the market in 2023. A solution is a mixture of two or more components that are combined to form a single phase that is homogenous at the molecular level. Compared to other dosage forms, a solution offers numerous advantages. In comparison to solid dosage forms, liquids are absorbed faster and cause less GI mucosa discomfort. Furthermore, unlike suspensions and emulsions, phase separation during storage is not an issue with solutions. The disadvantages of solutions include microbial contamination and the hydrolysis of sensitive active components in aqueous solution. Furthermore, certain medications have a more unpleasant taste when they are in solution.

Oral solutions are made up of a variety of additives, including buffers, tastes, antioxidants, and preservatives. CEVA SANT